Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nanoviricides Inc (NY: NNVC )

1.240 -0.070 (-5.34%)
Official Closing Price Updated: 8:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,658
Open 1.277
Bid (Size) 1.240 (1)
Ask (Size) 1.340 (1)
Prev. Close 1.310
Today's Range 1.230 - 1.277
52wk Range 1.040 - 3.880
Shares Outstanding 11,635,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats 
Via News Direct
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
By Ernest Dela Aglanu, Benzinga 
Via TheNewswire.com
Topics Death Economy
Exposures COVID-19 Death Economy

Performance

YTD
+9.73%
+9.73%
1 Month
-6.77%
-6.77%
3 Month
+3.33%
+3.33%
6 Month
-20.51%
-20.51%
1 Year
-46.09%
-46.09%

More News

Read More
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
Via News Direct
Topics Death
Exposures COVID-19 Death
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
Via TheNewswire.com
Topics Death
Exposures COVID-19 Death
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Via TheNewswire.com
Topics Death
Exposures COVID-19 Death
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
Via TheNewswire.com
Short Volatility Alert: NanoViricides, Inc.
Via Benzinga
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It, And To Prepare For Battling Against The Next Likely Coronavirus Pandemic
Via Benzinga
uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For Tuesday
Via Benzinga
NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials
Via ACCESSWIRE
NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
Via ACCESSWIRE
NanoViricides, Inc. to Present at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET
Via ACCESSWIRE
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027
Via FinancialNewsMedia
NanoViricides, Inc. Has Filed its Quarterly Report: Coronavirus Drug NV-CoV-2 IND Stage
Via ACCESSWIRE
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
Via InvestorPlace
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Via News Direct
Topics Death
Exposures COVID-19 Death
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Via Benzinga
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug NV-CoV-2 IND Stage
Via ACCESSWIRE
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
Via News Direct
Monkeypox Is Popping Up In Places It Shouldn't But NanoViricides Says It May Have A Solution
Via Benzinga
NanoViricides Provides Additional Details on Its Rapid Monkeypox Drug Strategy
Via ACCESSWIRE
NanoViricides Initiates New Drug Development To Combat Monkeypox Virus
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.